Personalized medicine for ARDS: the 2035 research agenda.
about
Effect of driving pressure on mortality in ARDS patients during lung protective mechanical ventilation in two randomized controlled trials.A path to precision in the ICU.Nanomedicine for the Treatment of Acute Respiratory Distress Syndrome. The 2016 ATS Bear Cage Award-winning Proposal.Fifty Years of Research in ARDS. The Epidemiology of Acute Respiratory Distress Syndrome. A 50th Birthday Review.Adjuvants to Mechanical Ventilation for Acute Respiratory Failure. Adoption, De-adoption, and Factors Associated with Selection.Bedside assessment of the effects of positive end-expiratory pressure on lung inflation and recruitment by the helium dilution technique and electrical impedance tomography.Bronchoalveolar Lavage Fluid Protein Expression in Acute Respiratory Distress Syndrome Provides Insights into Pathways Activated in Subjects with Different Outcomes.Preventing ventilator-induced lung injury-what does the evidence say?Unmasking a Role for Noninvasive Ventilation in Early Acute Respiratory Distress SyndromeFluid resuscitation targeting sepsis-induced cardiovascular dysfunction: severity of disease as effect modifier.Focus on ECMO and ECCO2R in ARDS patients.Association of Response to Inhaled Nitric Oxide and Duration of Mechanical Ventilation in Pediatric Acute Respiratory Distress Syndrome.Intensive care medicine in 2050: nanotechnology. Emerging technologies and approaches and their impact on critical care.Danger Signals in the ICU.Nucleated red blood cells as predictors of mortality in patients with acute respiratory distress syndrome (ARDS): an observational study.The 25th birthday and premature death of the open lung approach?-from science, through art, towards precision medicine.
P2860
Q37450127-70AB8AFA-D497-4313-9099-29E89E4CF908Q37733894-627DAAF2-5CD8-404B-B4E2-74B39D44392EQ38901651-F71C8611-0725-487A-8FE2-9CEF723A7D41Q39117798-F392B5DB-DB77-4438-9D05-C206233A3B9DQ39294641-9907978C-4396-4865-A07E-BEA9E4A0B547Q39495507-5E9FC24C-5790-456F-8053-E242A94BFD80Q41287577-7FF3751C-C4AF-411B-ADCD-F4857B8760A0Q42357391-C68DCCB4-D683-4348-A4B1-0C4F63F853F5Q42365186-891DF666-6DDA-4C68-94B6-CFAC60A6EC1BQ47151375-65E10A16-0C29-475A-BF68-38DCE1A40CE9Q47272796-E1D78913-C74A-4C90-B4D6-7ADB8A7E46E0Q47724485-768A2203-6BFE-4B71-926F-BD62F3791AEBQ48233774-86A1E40B-74BE-400D-AF0E-E16B57675826Q50002873-F4B472D4-5090-4D58-AC41-4752F091C9ADQ52806499-54AFDD9C-C1D0-4014-BF6A-98E101812D44Q53833864-18C6E17D-A348-4201-8B07-BF450A62CE01
P2860
Personalized medicine for ARDS: the 2035 research agenda.
description
2016 nî lūn-bûn
@nan
2016年の論文
@ja
2016年論文
@yue
2016年論文
@zh-hant
2016年論文
@zh-hk
2016年論文
@zh-mo
2016年論文
@zh-tw
2016年论文
@wuu
2016年论文
@zh
2016年论文
@zh-cn
name
Personalized medicine for ARDS: the 2035 research agenda.
@en
type
label
Personalized medicine for ARDS: the 2035 research agenda.
@en
prefLabel
Personalized medicine for ARDS: the 2035 research agenda.
@en
P2093
P2860
P1476
Personalized medicine for ARDS: the 2035 research agenda.
@en
P2093
ARDSne(x)t Investigators
Alberto Zanella
Alexandre B Cavalcanti
Ewan C Goligher
Ignacio Martin-Loeches
Jeremy R Beitler
Matthieu Schmidt
Peter M Spieth
P2860
P2888
P304
P356
10.1007/S00134-016-4331-6
P577
2016-04-04T00:00:00Z